Clinical Trial: A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)

U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07280156) titled 'A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)' on Dec. 03.

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled phase II study assessing the efficacy, safety, and dosing regimen selection of multiple IV infusions of PRX-115 over 24 weeks, with or without MTX, versus the respective placebos in adult patients with gout.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Gout

Intervention: BIOLOGICAL: PRX-115

intravenous (IV) infus...